XBiotech Inc.
XBIT
$2.20
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 850.00K | 1.07M | 4.40M | 967.00K | 1.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.15M | 6.27M | 29.76M | 6.05M | 6.34M |
| Operating Income | -6.15M | -6.27M | -29.76M | -6.05M | -6.34M |
| Income Before Tax | -6.68M | -5.46M | -26.82M | -5.91M | -1.73M |
| Income Tax Expenses | 46.00K | 49.00K | 76.00K | 102.00K | 28.00K |
| Earnings from Continuing Operations | -6.73M | -5.51M | -26.89M | -6.01M | -1.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.73M | -5.51M | -26.89M | -6.01M | -1.76M |
| EBIT | -6.15M | -6.27M | -29.76M | -6.05M | -6.34M |
| EBITDA | -5.84M | -5.94M | -29.38M | -5.62M | -5.90M |
| EPS Basic | -0.22 | -0.18 | -0.88 | -0.20 | -0.06 |
| Normalized Basic EPS | -0.14 | -0.11 | -0.56 | -0.12 | -0.04 |
| EPS Diluted | -0.22 | -0.18 | -0.88 | -0.20 | -0.06 |
| Normalized Diluted EPS | -0.14 | -0.11 | -0.56 | -0.12 | -0.04 |
| Average Basic Shares Outstanding | 30.49M | 30.49M | 30.49M | 30.49M | 30.49M |
| Average Diluted Shares Outstanding | 30.49M | 30.49M | 30.49M | 30.49M | 30.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |